No image

ARK™ Levetiracetam Assay

The ARK™ Levetiracetam Assay is a homogeneous enzyme immunoassay intended for the quantitative determination of Levetiracetam in human serum or plasma on automated clinical chemistry analyzers. Levetiracetam concentrations can be used as an aid in management of patients treated with Levetiracetam. The ARK™ Levetiracetam Assay consists of reagents RI anti-Levetiracetam polyclonal antibody with substrate and R2 Levetiracetam epitope labeled with bacterial G6PDH enzyme.

Details

Device typeLevetiracetam therapeutic drug monitoring IVD, reagent: A substance or reactant intended to be used together with a parent IVD to perform a specific function in an assay that is used for the quantitative measurement and therapeutic monitoring of the central nervous system drug levetiracetam (e.g., Keppra) in a clinical specimen.

FDA categoryLevetiracetam Assay

Device ID00858724003032

Catalog number5024-0001-00

AvailabilityPrescription

Single useYes

MRI safetyLabeling does not contain MRI Safety Information

Contact

Phone5102706270

Emailcustomersupport@ark-tdm.com

Related products

Product	Model	Company	Device type
ARK™ Levetiracetam II CalibratorArk Diagnostics IncLevetiracetam therapeutic drug monitoring IVD, calibrator	5070-0002-00	Ark Diagnostics Inc	Levetiracetam therapeutic drug monitoring IVD, calibrator
ARK™ Lamotrigine AssayArk Diagnostics IncMultiple anticonvulsant therapeutic drug monitoring IVD, reagent	5023-0001-00	Ark Diagnostics Inc	Multiple anticonvulsant therapeutic drug monitoring IVD, reagent
ARK™ Oxcarbazepine Metabolite AssayArk Diagnostics IncMultiple anticonvulsant therapeutic drug monitoring IVD, reagent	5032-0001-00	Ark Diagnostics Inc	Multiple anticonvulsant therapeutic drug monitoring IVD, reagent
ARK™ Pregabalin II AssayArk Diagnostics IncMultiple anticonvulsant therapeutic drug monitoring IVD, reagent	5059-0001-01	Ark Diagnostics Inc	Multiple anticonvulsant therapeutic drug monitoring IVD, reagent